La bourse ferme dans 32 min
  • CAC 40

    5 809,54
    -0,19 (-0,00 %)
     
  • Euro Stoxx 50

    3 699,78
    -7,94 (-0,21 %)
     
  • Dow Jones

    31 494,15
    +102,63 (+0,33 %)
     
  • EUR/USD

    1,2079
    -0,0009 (-0,07 %)
     
  • Gold future

    1 705,00
    -28,60 (-1,65 %)
     
  • BTC-EUR

    41 979,68
    +1 128,46 (+2,76 %)
     
  • CMC Crypto 200

    1 014,27
    +26,18 (+2,65 %)
     
  • Pétrole WTI

    61,31
    +1,56 (+2,61 %)
     
  • DAX

    14 019,32
    -20,48 (-0,15 %)
     
  • FTSE 100

    6 643,56
    +29,81 (+0,45 %)
     
  • Nasdaq

    13 231,84
    -126,94 (-0,95 %)
     
  • S&P 500

    3 858,64
    -11,65 (-0,30 %)
     
  • Nikkei 225

    29 559,10
    +150,93 (+0,51 %)
     
  • HANG SENG

    29 880,42
    +784,56 (+2,70 %)
     
  • GBP/USD

    1,3972
    +0,0016 (+0,11 %)
     

The Global Parkinsons Disease (PD) Drugs Market is expected to grow by $ 1.57 bn during 2020-2024, progressing at a CAGR of 6% during the forecast period

ReportLinker
·2 min de lecture

Global Parkinsons Disease (PD) Drugs Market 2020-2024 The analyst has been monitoring the Parkinson’s disease (PD) drugs market and it is poised to grow by $ 1. 57 bn during 2020-2024, progressing at a CAGR of 6% during the forecast period.

New York, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Parkinsons Disease (PD) Drugs Market 2020-2024" - https://www.reportlinker.com/p06007818/?utm_source=GNW
Our report on Parkinson’s disease (PD) drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the new drug launches and strong drug pipeline. In addition, new drug launches is anticipated to boost the growth of the market as well.
The Parkinson’s disease (PD) drugs market analysis includes drug class segments and geographical landscapes.

The Parkinson’s disease (PD) drugs market is segmented as below:
By Drug Class
• DA and levodopa-carbidopa
• MAO inhibitors
• AChE inhibitors
• glutamate inhibitors
• others

By Geographical Landscapes
• Europe
• North America
• Asia
• ROW

This study identifies the rise in geriatric population as one of the prime reasons driving the Parkinson’s disease (PD) drugs market growth during the next few years.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on Parkinson’s disease (PD) drugs market covers the following areas:
• Parkinsons disease (PD) drugs market sizing
• Parkinsons disease (PD) drugs market forecast
• Parkinsons disease (PD) drugs market industry analysis


Read the full report: https://www.reportlinker.com/p06007818/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001